2IA.F · iAnthus Capital Holdings, Inc

-

Please sign in to comment on 2IA.F

1 Comment

Admin

3 years, 7 months ago

iAnthus Capital Holdings, Inc is currently in a long term downtrend where the price is trading 23.9% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.

iAnthus Capital Holdings, Inc's total revenue rose by 49.2% to $41M since the same quarter in the previous year.

Its net income has increased by 96.2% to $-10M since the same quarter in the previous year.

Finally, its free cash flow grew by 69.5% to $-7M since the same quarter in the previous year.

Based on the above factors, iAnthus Capital Holdings, Inc gets an overall score of 4/5.

ISIN	CA45074T1021
Sector	Healthcare
Industry	Drug Manufacturers-Specialty & Generic
CurrencyCode	EUR
Exchange	F

Beta	1.6
Dividend Yield	0.0%
Target Price	0.05
PE Ratio	None
Market Cap	92M

ABOUT

iAnthus Capital Holdings, Inc

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in New York, New York.

2IA.F · iAnthus Capital Holdings, Inc

-

iAnthus Capital Holdings, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest iAnthus Capital Holdings, Inc using a moving average strategy